Sirnaomics (HKSE:02257) YoY EBITDA Growth : 86.78% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sirnaomics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Sirnaomics's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 86.78%.

Sirnaomics's EBITDA per Share for the six months ended in Dec. 2024 was HK$-0.58.

Sirnaomics YoY EBITDA Growth Historical Data

The historical data trend for Sirnaomics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirnaomics YoY EBITDA Growth Chart

Sirnaomics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-179.07

-2,718.75

91.53

15.76

39.77

Sirnaomics Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial					94.58	12.76	14.12	-6.45	86.78

Sirnaomics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Sirnaomics's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-4.815	-	-7.994)	/	\| -7.994 \|
=	39.77 %

Sirnaomics's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(-0.582	-	-4.403)	/	\| -4.403 \|
=	86.78 %

Sirnaomics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Sirnaomics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirnaomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirnaomics Ltd (HKSE:02257) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

V5Z:Germany

Address

No.218 Xinghu Street, Unit 415, A4 Building, Suzhou Industrial Park, Suzhou, CHN

Website

https://www.sirnaomics.com

Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China.

Executives

Poon Hung Fai	2101 Beneficial owner
Lu Yang	2101 Beneficial owner
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Dai Xiaochang	2201 Interest of corporation controlled by you
Yan Xia Ling	2202 Interest of your spouse
Ceng Yu	2201 Interest of corporation controlled by you
Li Jie	2201 Interest of corporation controlled by you
Li Lele	2202 Interest of your spouse
Shanghai Chongshi Enterprise Management Partnership(lp)	2101 Beneficial owner
Shenzhen Qianhai Rotating Boulder Fund Management Co.,ltd	2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Second Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Third Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you

Sirnaomics Headlines

No Headlines